• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.

作者信息

Schulman Sam

机构信息

Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada.

Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.

出版信息

Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.

DOI:10.1055/s-0040-1710337
PMID:32392613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7645820/
Abstract
摘要

相似文献

1
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
2
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
3
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南
J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.
4
Hematological findings and complications of COVID-19.COVID-19 的血液学表现及并发症。
Am J Hematol. 2020 Jul;95(7):834-847. doi: 10.1002/ajh.25829. Epub 2020 May 23.
5
Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.简要研究：新型冠状病毒肺炎中的凝血功能障碍：确定和管理新型冠状病毒肺炎感染中的血栓形成风险
Clin Med (Lond). 2020 Jul;20(4):e59. doi: 10.7861/clinmed.rib.20.4.2.
6
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
7
Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.2019年重症冠状病毒感染中高凝状态间接标志物与血栓弹力图的相关性
Thromb Res. 2020 Nov;195:69-71. doi: 10.1016/j.thromres.2020.07.013. Epub 2020 Jul 9.
8
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.COVID-19：凝血功能障碍、血栓形成风险和抗凝治疗的理由。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
9
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.新冠肺炎癌症患者的血栓形成与止血问题
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
10
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.用于预防和管理新型冠状病毒肺炎血栓形成的药物治疗
Semin Thromb Hemost. 2020 Oct;46(7):789-795. doi: 10.1055/s-0040-1714273. Epub 2020 Aug 20.

引用本文的文献

1
Molecular docking of polyphenol compounds and exploring the anticoagulant activity of extracts and .多酚化合物的分子对接以及提取物和……的抗凝活性研究
Toxicol Rep. 2025 Feb 19;14:101961. doi: 10.1016/j.toxrep.2025.101961. eCollection 2025 Jun.
2
Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy.两例与腺病毒载体疫苗ChAdOx1-S（阿斯利康）相关的免疫性血小板减少症（ITP）及血小板生成素受体激动剂（TPO-RA）治疗后的良好反应
Hematol Rep. 2024 Sep 27;16(4):585-592. doi: 10.3390/hematolrep16040057.
3
Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke.2019冠状病毒病相关卒中的流行病学、发病机制及管理
Front Med. 2023 Dec;17(6):1047-1067. doi: 10.1007/s11684-023-1041-7. Epub 2024 Jan 2.
4
Clinical Outcomes of Anticoagulant Therapy in COVID-19 Patients with Pre-Existing Cardiovascular Diseases: A Systematic Review.新冠病毒病合并心血管疾病患者抗凝治疗的临床结局：一项系统评价
Infect Drug Resist. 2023 Jun 14;16:3767-3775. doi: 10.2147/IDR.S410374. eCollection 2023.
5
Central retinal vein occlusion and occlusive vasculopathy at macula in a patient with recent COVID-19 infection.一名近期感染新型冠状病毒肺炎患者的视网膜中央静脉阻塞及黄斑部闭塞性血管病变
Taiwan J Ophthalmol. 2022 Aug 5;12(4):477-481. doi: 10.4103/tjo.tjo_15_22. eCollection 2022 Oct-Dec.
6
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.新冠病毒病（Covid-19）对常规实验室检测肝素诱导的血小板减少症能力的潜在影响。
Thromb J. 2022 Sep 26;20(1):55. doi: 10.1186/s12959-022-00411-0.
7
Does COVID-19 infection increase the risk of pressure injury in critically ill patients?: A narrative review.新型冠状病毒肺炎感染是否会增加危重症患者发生压力性损伤的风险？：一项叙述性综述。
Medicine (Baltimore). 2022 Mar 18;101(11). doi: 10.1097/MD.0000000000029058.
8
Subacute dual stent thromboses in a COVID-19-positive patient.COVID-19 阳性患者的亚急性双重支架血栓形成。
Cardiovasc J Afr. 2022;33(6):329-332. doi: 10.5830/CVJA-2022-003. Epub 2022 Mar 24.
9
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases.2019冠状病毒病，世纪大流行及其对心血管疾病的影响。
Cardiol Discov. 2021 Nov 22;1(4):233-258. doi: 10.1097/CD9.0000000000000038. eCollection 2021 Dec.
10
Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study.4742例新冠肺炎或其他急性感染性呼吸道疾病患者血栓形成并发症的发生率及预测因素：一项倾向评分匹配研究
J Clin Med. 2021 Oct 26;10(21):4973. doi: 10.3390/jcm10214973.

本文引用的文献

1
COVID-19 Complicated by Acute Pulmonary Embolism.新型冠状病毒肺炎合并急性肺栓塞
Radiol Cardiothorac Imaging. 2020 Mar 16;2(2):e200067. doi: 10.1148/ryct.2020200067. eCollection 2020 Apr.
2
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
3
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
4
Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review.新型冠状病毒病 2019（COVID-19）的胸部 CT 表现：影像学综述。
Eur Radiol. 2020 Aug;30(8):4381-4389. doi: 10.1007/s00330-020-06801-0. Epub 2020 Mar 19.
5
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism?肺血栓栓塞症：一种与肺栓塞不同的临床病理实体？
Semin Thromb Hemost. 2019 Nov;45(8):778-783. doi: 10.1055/s-0039-1696942. Epub 2019 Sep 19.